APA

Dolle R. E., Singh J., Whipple D., Osifo I. K., Speier G., Graybill T. L., Gregory J. S., Harris A. L., Helaszek C. T. & Miller R. E. (19950223). Aspartyl alpha-((diphenylphosphinyl)oxy)methyl ketones as novel inhibitors of interleukin-1 beta converting enzyme. Utility of the diphenylphosphinic acid leaving group for the inhibition of cysteine proteases. : Journal of medicinal chemistry.

Chicago

Dolle R E, Singh J, Whipple D, Osifo I K, Speier G, Graybill T L, Gregory J S, Harris A L, Helaszek C T and Miller R E. 19950223. Aspartyl alpha-((diphenylphosphinyl)oxy)methyl ketones as novel inhibitors of interleukin-1 beta converting enzyme. Utility of the diphenylphosphinic acid leaving group for the inhibition of cysteine proteases. : Journal of medicinal chemistry.

Harvard

Dolle R. E., Singh J., Whipple D., Osifo I. K., Speier G., Graybill T. L., Gregory J. S., Harris A. L., Helaszek C. T. and Miller R. E. (19950223). Aspartyl alpha-((diphenylphosphinyl)oxy)methyl ketones as novel inhibitors of interleukin-1 beta converting enzyme. Utility of the diphenylphosphinic acid leaving group for the inhibition of cysteine proteases. : Journal of medicinal chemistry.

MLA

Dolle R E, Singh J, Whipple D, Osifo I K, Speier G, Graybill T L, Gregory J S, Harris A L, Helaszek C T and Miller R E. Aspartyl alpha-((diphenylphosphinyl)oxy)methyl ketones as novel inhibitors of interleukin-1 beta converting enzyme. Utility of the diphenylphosphinic acid leaving group for the inhibition of cysteine proteases. : Journal of medicinal chemistry. 19950223.